Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy of HIV PrEP and STI PEP for Young Men

NCT07658976 is registered in ClinicalTrials.gov with HIV Prevention Trials Network as lead sponsor.

NCT NCT07658976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07658976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy of HIV PrEP and STI PEP for Young Men
Lead sponsor
HIV Prevention Trials Network
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
September 1, 2029
Enrollment
400 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection, sexually transmitted infection